Skip to content

Talphera, Inc. TLPH Change in AR

Change in AR at other companies

Baxter International logo
Baxter InternationalBAX
-$152M-485%
AMP
Amphastar PharmaceuticalsAMPH
$4.55M-43.7%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-$120K-101%
PTH
Pelthos Therapeutics Inc.PTHS
$2.84M
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
-$1.82M-2,574%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
-$6.41M-1,213%

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+516%
P/S53,456.6×+53,135×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Reported directly by Talphera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Talphera, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s change in AR?
Talphera, Inc. (TLPH) reported change in AR of -$0 in Q1 2026.
How has Talphera, Inc.'s change in AR changed year-over-year?
Talphera, Inc.'s change in AR decreased by 100.0% year-over-year, from $27K to -$0.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.